Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) does not have distinct and highly sensitive bi...
INTRODUCTION: Prostate adenocarcinoma (PRAD) is an extremely widespread site of urological malignanc...
BACKGROUND: Microvascular invasion (MVI) is strongly associated with the prognosis of patients with ...
BACKGROUND: Epithelial ovarian cancer (EOC) is a deadly and heterogenous disease comprising five maj...
OBJECTIVE: Oral cavity carcinomas (OCCs) represent roughly 50% of all head and neck cancers. The ris...
Sarcomas, a rare and complex group of cancers, require multidisciplinary care across multiple health...
OBJECTIVES: Lymphovascular invasion significantly impacts the prognosis of urothelial carcinoma of t...
PURPOSE: The study aimed to develop machine learning (ML) models for pretherapy prediction of absorb...
Artificial intelligence (AI) has emerged as a promising field in the era of personalized oncology d...
The investigation and diagnosis of hematologic malignancy using blood cell image analysis are major ...
PURPOSE: High-grade clear cell renal cell carcinoma (ccRCC) is linked to lower survival rates and mo...
: Despite great efforts from both clinical and pathological sides to address the extent of metastati...
OBJECTIVE: To develop an interpretable machine learning (ML) model using dynamic contrast-enhanced m...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the predominant subtype of renal cancer, with...
PURPOSE: To develop and validate a predictor for early treatment response in hepatocellular carcinom...
Gold standard for immunohistochemical analyses is the manual assessment by two specialist pathologis...
Hepatocellular carcinoma (HCC) is an aggressive cancer with limited biomarkers for predicting immuno...
Tumor budding (TB) and poorly differentiated clusters (PDCs) are features of infiltrative growth pat...
Gestational diabetes mellitus (GDM) and preeclampsia (PE) are common and serious disorders of pregna...
BACKGROUND: How to screen beneficiary populations has always been a clinical challenge in the treatm...